FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Ambey Laboratories IPO and Effwa Infra and Research IPO.
Ambey Laboratories IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Effwa Infra and Research IPO is a SME Book Built Issue proposed to list at NSE SME.
Ambey Laboratories IPO | Effwa Infra and Research IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Fast Track Finsec Pvt Ltd | Shreni Shares Limited |
Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
Market Maker | Nikunj Stock Brokers Limited | Rikhav Securities Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ambey Laboratories IPO is up to ₹44.68 Cr whereas the issue size of the Effwa Infra and Research IPO is up to ₹51.27 Cr. The final issue price of Ambey Laboratories IPO is ₹68.00 per share and of Effwa Infra and Research IPO is ₹82.00 per share.
Ambey Laboratories IPO | Effwa Infra and Research IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹65.00 per share | ₹78.00 per share |
Issue Price (Upper) | ₹68.00 per share | ₹82.00 per share |
Issue Price (Final) | ₹68.00 per share | ₹82.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 2000 shares | 1600 shares |
Fresh Issue Size | 62,58,000 shares | 53,16,800 shares |
Fresh Issue Size (Amount) | up to ₹42.55 Cr | up to ₹43.60 Cr |
OFS Issue Size | 3,12,000 shares | 9,36,000 shares |
OFS Issue Size (Amount) | up to ₹2.12 Cr | up to ₹7.68 Cr |
Issue Size Total | 65,70,000 shares | 62,52,800 shares |
Issue Size Total (Amount) | up to ₹44.68 Cr | up to ₹51.27 Cr |
Ambey Laboratories IPO opens on Jul 04, 2024, while Effwa Infra and Research IPO opens on Jul 05, 2024. The closing date of Ambey Laboratories IPO and Effwa Infra and Research IPO is Jul 08, 2024, and Jul 09, 2024, respectively.
Ambey Laboratories IPO | Effwa Infra and Research IPO | |
---|---|---|
Anchor Bid Date | Jul 03, 2024 | Jul 04, 2024 |
Issue Open | Jul 04, 2024 | Jul 05, 2024 |
Issue Close | Jul 08, 2024 | Jul 09, 2024 |
Basis Of Allotment (Tentative) | Jul 09, 2024 | Jul 10, 2024 |
Initiation of Refunds (Tentative) | Jul 10, 2024 | Jul 11, 2024 |
Credit of Share (Tentative) | Jul 10, 2024 | Jul 11, 2024 |
Listing date (Tentative) | Jul 11, 2024 | Jul 12, 2024 |
Anchor Lockin End date 1 | Aug 08, 2024 | Aug 09, 2024 |
Anchor Lockin End date 2 | Oct 07, 2024 | Oct 08, 2024 |
Ambey Laboratories IPO P/E ratio is 27.81, as compared to Effwa Infra and Research IPO P/E ratio of 10.59.
Ambey Laboratories IPO | Effwa Infra and Research IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Ambey Laboratories Limited Financial Information (Restated)
|
Effwa Infra & Research Limited Financial Information (Restated)Effwa Infra & Research Limited's revenue increased by 26.08% and profit after tax (PAT) rose by 169% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 94.97% | 99.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 69.90% | 72.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 27.81 | 10.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹171.64 Cr. | ₹189.81 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 20.80%% | 45.46%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 13.14%% | 40.99%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.58 | 0.38 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹2.44 | ₹7.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 20.80%% | 37.15%% |
In the Ambey Laboratories IPO retail investors (RII) are offered 21,84,000 shares while in Effwa Infra and Research IPO retail investors are offered 21,84,000 shares. Qualified institutional buyers (QIB) are offered 12,52,000 shares in Ambey Laboratories IPO and 11,68,000 shares in Effwa Infra and Research IPO.
Ambey Laboratories IPO | Effwa Infra and Research IPO | |
---|---|---|
Anchor Investor Reserveration | 18,72,000 shares | 17,48,800 shares |
Market Maker Reserveration | 3,30,000 shares | 3,24,800 shares |
QIB | 12,52,000 shares | 11,68,000 shares |
NII | 6,06,001 shares | 9,20,000 shares |
RII | 21,84,000 shares | 20,91,200 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 40,42,001 shares | 41,79,200 shares |
Ambey Laboratories IPO subscribed 173.18x in total, whereas Effwa Infra and Research IPO subscribed 313.65x.
Ambey Laboratories IPO | Effwa Infra and Research IPO | |
---|---|---|
QIB (times) | 61.90x | 166.56x |
NII (times) | 324.22x | 477.27x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 195.06x | 323.81x |
Employee (times) | ||
Other (times) | ||
Total (times) | 173.18x | 313.65x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|